Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis
NCT01125644
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
10
Enrollment
INDUSTRY
Sponsor class
Conditions
Cryptococcosis or Aspergillosis Infections
Interventions
DRUG:
SPK-843
Sponsor
Proaparts srl